Lead author of major breast cancer study announced at ASCO co-authored two corrected papers with Anil Potti

One of the biggest stories so far out of the American Society of Clinical Oncology (ASCO) meeting that just ended in Chicago was that of T-DM1, which, according to Ivan’s Reuters colleagues, “extended the length of time breast cancer patients lived without their disease getting worse.” (The news was even the subject of an embargo break.)

The widely-hailed study of Roche’s drug was led by Duke’s Kimberly Blackwell, who told The New York Times: Continue reading Lead author of major breast cancer study announced at ASCO co-authored two corrected papers with Anil Potti

Millennium Villages Project forced to correct Lancet paper on foreign aid as leader leaves team

A senior member of a high-profile foreign aid research team has left the project on the heels of a Lancet correction of a heavily criticized paper the team published earlier this month.

Paul Pronyk, who until last week was director of monitoring and evaluation at Columbia University’s Center for Global Health and Economic Development, which runs the Millennium Villages Project, wrote a letter to the Lancet acknowledging errors in the paper, “The effect of an integrated multisector model for achieving the Millennium Development Goals and improving child survival in rural sub-Saharan Africa: a non-randomised controlled assessment,” originally published May 8. That admission came after Jesse Bump, Michael Clemens, Gabriel Demombynes, and Lawrence Haddad wrote a letter criticizing the work, which was published this week accompanied by corrections to the paper: Continue reading Millennium Villages Project forced to correct Lancet paper on foreign aid as leader leaves team

JACS makes it official, retracting Breslow “space dinosaurs” paper for “similarity to his previously published reviews”

Last month, we (and others) reported that the Journal of the American Chemical Society (JACS) had temporarily withdrawn a paper by a former president of the society after a number of chemists pointed out similarities between the March 25 article and previous ones by the author, Ronald Breslow.

The paper had drawn puzzled looks thanks to an April 11 press release — since deleted — headlined “Could ‘advanced’ dinosaurs rule other planets?” In its note last month, the journal said: Continue reading JACS makes it official, retracting Breslow “space dinosaurs” paper for “similarity to his previously published reviews”

Retraction seven for Shouwei Han, this one in the American Journal of Physiology

ShouWei Han, who has been forced to retract six papers from various physiology journals following an investigation into his work by his former employer, the University of Louisville, has added another one to his tally.

Here’s the notice, from the American Journal of Physiology: Lung Cellular and Molecular Physiology: Continue reading Retraction seven for Shouwei Han, this one in the American Journal of Physiology

JACS temporarily pulls “space dinosaurs” paper for alleged duplication

Duplication has, as we noted on Twitter the other day, been tripping up more and more scientists. And now self-plagiarism has snared a prominent Columbia University chemist in a paper that left many people scratching their heads to begin with.

As reported by the Chembark blog and Nature, the Journal of the American Chemical Society (JACS) has pulled a paper by Ronald Breslow for alleged duplication. The page for “On Evidence for the Likely Origin of Homochirality in Amino Acids, Sugars, and Nucleosides on Prebiotic Earth,” originally published on March 25, now includes this: Continue reading JACS temporarily pulls “space dinosaurs” paper for alleged duplication

Group investigated by University of Louisville corrects lung cancer paper after retracting six others

A group of researchers whose work has been under investigation at the University of Louisville has issued a correction for a paper in the American Journal of Respiratory Cell and Molecular Biology (AJRCMB).

The correction follows three retractions each in the Journal of Biological Chemistry and the AJRCMB, the latter of which made it clear that lab member ShouWei Han was responsible for the manipulations and duplications that brought down the papers. Here’s the new notice, which appeared in the March 1, 2012 issue of the journal: Continue reading Group investigated by University of Louisville corrects lung cancer paper after retracting six others

A “retraction in part” for Anil Potti and colleagues, in Molecular Cancer Therapeutics

A partial retraction has joined the ten retractions and five corrections of Anil Potti’s papers, this one of a 2008 paper in Molecular Cancer Therapeutics. The move comes 14 months after the retraction of the Nature Medicine paper upon which much of the Molecular Cancer Therapeutics paper was based.

Here’s the notice: Continue reading A “retraction in part” for Anil Potti and colleagues, in Molecular Cancer Therapeutics

Society error leads to published — then retracted — Alzheimer’s abstract from top group

Alzheimer’s & Dementia has retracted a meeting abstract the journal published without the OK of the researchers, a top group from Harvard, who submitted it but withdrew the work before the conference.

That, as they say, might require some unpacking. Maybe this will make things clearer.

Raj Hooli, a graduate student in the lab of Rudolph Tanzi, a leading neuroscientist at Harvard — where he holds the Joseph P. and Rose F. Kennedy endowed chair of neurology — had submitted the abstract, “Genome-wide assessment of copy number variations in early-onset Alzheimer’s disease,” for consideration at the International Conference on Alzheimer’s Disease (ICAD).

As Tanzi explains: Continue reading Society error leads to published — then retracted — Alzheimer’s abstract from top group

Two more retractions in respiratory journal as University of Louisville completes investigation

Last July, we reported on four retractions by a group of researchers at the University of Louisville, and we noted that the scientists’ work was under investigation. That investigation has apparently concluded, according to a retraction notice in the American Journal of Respiratory Cell and Molecular Biology for two of their papers: Continue reading Two more retractions in respiratory journal as University of Louisville completes investigation

JAMA awaiting final OHRP decision on Harvard-led paper whose authors didn’t fully disclose risks to elderly

Earlier this month, the U.S. Office for Human Research Protections (OHRP) told a group of researchers led by a Harvard Medical School professor that they hadn’t been forthcoming enough about the risks elderly subjects faced in their trial.

As the Boston Globe reported: Continue reading JAMA awaiting final OHRP decision on Harvard-led paper whose authors didn’t fully disclose risks to elderly